Provided by Tiger Trade Technology Pte. Ltd.

First Trust Nasdaq Pharmaceuticals ETF

42.01
-0.2494-0.59%
Volume:310.99K
Turnover:13.08M
Market Cap:1.06B
PE:- -
High:42.12
Open:41.88
Low:41.83
Close:42.26
52wk High:42.87
52wk Low:27.30
Shares:25.15M
Float Shares:25.15M
Volume Ratio:3.95
T/O Rate:1.24%
Dividend:0.42
Dividend Rate:1.01%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Johnson & Johnson Stock Shines on Dividends and Lung Cancer Bet

TIPRANKS
·
Aug 22

Merck & Company Soars on Breakthrough Cancer Vaccine Hopes

TIPRANKS
·
Aug 22

Broadcom Stock Headlines 3 Cash Flow Picks Trading Below Fair Value

Simply Wall St.
·
Aug 22

Johnson & Johnson, AbbVie, Chevron, Energy Transfer, Home Depot Shaken

TIPRANKS
·
Aug 22

Moderna, ADI, Merck, EPR, TJX: Trending With Analysts

TIPRANKS
·
Aug 22

How a Big Bet on Cancer Vaccines Brought Moderna Back from the Brink

Dow Jones
·
Aug 22

Top Stock Market Highlights of the Week: Sembcorp Industries, Singapore’s Big Three Banks, Moderna and CapitaLand Investment

The Smart Investor
·
Aug 22

Novavax Inc. Stock Rises 6.2%, Outperforms Peers

Dow Jones
·
Aug 22

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 22

Johnson & Johnson Names New Vice President for Litigation

Reuters
·
Aug 22

Stocks Ex-Dividend August 25

Dow Jones
·
Aug 22

Goldman Sachs, Merck Share Gains Contribute to Dow's 500-Point Jump

Dow Jones
·
Aug 22

US Equity Indexes Lower This Week as Trump Threatens Major Economic War on Iran

MT Newswires Live
·
Aug 22

Merck Price Target Raised to $160.00/Share from $140.00 by Goldman Sachs

Dow Jones
·
Aug 22

AbbVie Expands Aesthetics Pipeline With New Phase 2 Forehead Lines Study

TIPRANKS
·
Aug 22

Eli Lilly Targets Ramadan Diabetes Market With New Orforglipron Trial

TIPRANKS
·
Aug 22

Bristol-Myers Squibb Adds Early Alzheimer’s Antibody To Its Long-Term Growth Story

TIPRANKS
·
Aug 22

AbbVie Targets Pediatric Alopecia With New Phase 3 Trial: What Investors Should Watch

TIPRANKS
·
Aug 22

Eli Lilly’s Dulaglutide Study Sheds Light on Fasting Risks and Diabetes Care

TIPRANKS
·
Aug 22

AbbVie’s Emraclidine Schizophrenia Study Ends Early: What Investors Need to Know Now

TIPRANKS
·
Aug 22